FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical compositions comprising positive modulator of nicotine receptor agonist and agonist of nicotine receptor wherein indicated positive modulator shows ability to enhance effectiveness of nicotine receptor agonist. Indicated composition is used for treatment of state associated with reduced transfer in nicotine receptor, in particular, in Alzheimer's disease, schizophrenia and others. Invention claims also method for identification of positive modulator of nicotine receptor agonist. Invention provides the enhancement of activity of nicotine receptor agonist. EFFECT: valuable medicinal properties of composition. 21 cl, 6 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
1,3,5-TRISUBSTITUTED TRIAZOLE DERIVATIVE | 2008 |
|
RU2476433C2 |
AMIDES OF DIASABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINIC RECEPTORS | 2007 |
|
RU2517693C2 |
AMIDES OF DIAZABICYCLOALKANES, SELECTIVE WITH RESPECT TO ACETYLCHOLINE SUBTYPE OF NICOTINE RECEPTORS AND PHARMACEUTIC COMPOSITION AND METHODS OF TREATMENT WITH THEIR APPLICATION | 2007 |
|
RU2448969C2 |
NICOTINIC RECEPTOR LIGANDS | 2007 |
|
RU2441007C2 |
NON-COMPETITIVE NICOTINIC RECEPTOR ANTAGONISTS | 2011 |
|
RU2582339C2 |
POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR | 2012 |
|
RU2604737C2 |
ORGANIC COMPOUNDS | 2012 |
|
RU2610094C2 |
(2S,3R-)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2,2,2]OCT-3-YL)BENZOFURANE-2-CARBOXAMIDE, NEW SALT FORMS AND METHODS FOR PREPARING THEM | 2008 |
|
RU2476220C2 |
AGONISTS OF NICOTINE RECEPTORS IN TREATMENT OF INFLAMMATORY DISEASES | 2002 |
|
RU2299731C2 |
COMPOSITIONS AND METHODS OF TREATING PARANASAL SINUS AND PARASITIC NASAL MUCOSA DISEASES WITH NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS | 2017 |
|
RU2718061C1 |
Authors
Dates
2004-03-10—Published
1999-04-28—Filed